SeaStar Medical Holding Corp ICU
SeaStar Medical Holding Corp (Nasdaq: ICU) is a cardio-renal-metabolic medical device company. Its next catalyst on record is Adult SCD (NEUTRALIZE-AKI): Report topline pivotal results and, if successful, submit PMA application (2027).
Upcoming catalysts
No catalyst is dated to the next 30 days or to an FDA action date.
Next further out: Adult SCD (NEUTRALIZE-AKI) — Report topline pivotal results and, if successful, submit PMA application (2027). 1 catalyst on record beyond the next 30 days; subscribers see each with its filing sentence.
Pipeline
| Program | Indication | Modality | Stage |
|---|---|---|---|
| QUELIMMUNE (pediatric SCD) | Pediatric AKI due to sepsis requiring kidney replacement therapy | device-combination | NA_NON_THERAPEUTIC |
| Adult SCD (NEUTRALIZE-AKI pivotal trial) | Adult AKI requiring CRRT | device-combination | NA_NON_THERAPEUTIC |
| SCD feasibility study in cardiorenal syndrome awaiting LVAD | Cardiorenal syndrome | device-combination | NA_NON_THERAPEUTIC |
For subscribers
- Cash runway against each catalyst, with the company's own runway statement
- Track record: every Phase 3 readout, FDA decision and guidance slip since 2014
- Expected move for each dated catalyst, from comparable past events
- Phase 2 evidence behind each Phase 3 readout
- Companies on the same target or class
- Full catalyst list with filing sentences, deals, registered trials, Excel export
Other cardio-renal-metabolic companies
- DexCom, Inc. DXCM
- Penumbra Inc PEN
- Insulet Corp PODD
- MiniMed Group, Inc. MMED
- Heartflow, Inc. HTFL
- iRhythm Holdings, Inc. IRTC
- Pulse Biosciences, Inc. PLSE
- AtriCure, Inc. ATRC
The free Monday brief
Last week's readouts and FDA decisions and the dated catalysts in the week ahead, each with its filing sentence.